Integra LifeSciences Highlights CUSA Technology at ACS Clinical Congress 2026
Event summary
- Integra LifeSciences celebrates 20 years of CUSA® technology at the ACS Clinical Congress 2026, held September 26-29 in Washington, D.C.
- The company will feature surgeon-led educational programming focused on liver surgery, including presentations on the CUSA Clarity Ultrasonic Surgical Aspirator System and MicroFrance® laparoscopic surgical instrumentation.
- Internationally recognized liver surgeons Goro Honda and Adnan Alseidi will present clinical perspectives and experiences with complex liver procedures.
- Over 800,000 people are diagnosed with liver cancer worldwide each year, highlighting the importance of continued education and collaboration in liver surgery.
The big picture
Integra LifeSciences' participation in the ACS Clinical Congress 2026 underscores its commitment to advancing surgical education and innovation. The focus on liver surgery aligns with the growing global burden of liver cancer, highlighting the strategic importance of CUSA technology in addressing complex hepatobiliary conditions. The company's emphasis on building upon proven technologies while addressing evolving clinical needs positions it as a key player in the medical technology sector.
What we're watching
- Technology Adoption
- How the 20-year milestone for CUSA technology will influence its adoption in complex liver procedures.
- Market Positioning
- Whether Integra LifeSciences can sustain its leadership in surgical innovation amidst evolving clinical needs.
- Educational Impact
- The pace at which surgeon-led educational programming will drive advancements in liver surgery techniques.
